Ö. G. SEVİNDİK Et Al. , "Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities," 13 th International Symposium on Myelodysplastic Syndromes , vol.39, pp.5123, 2015
SEVİNDİK, Ö. G. Et Al. 2015. Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities. 13 th International Symposium on Myelodysplastic Syndromes , 5123.
SEVİNDİK, Ö. G., GUC, Z., KAHRAMAN, S., SOLMAZ, Ş., KATGI, A., ACAR, C., ... ALACACIOĞLU, İ.(2015). Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities . 13 th International Symposium on Myelodysplastic Syndromes (pp.5123).
SEVİNDİK, Ömür Et Al. "Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities," 13 th International Symposium on Myelodysplastic Syndromes, 2015
SEVİNDİK, Ömür G. Et Al. "Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities." 13 th International Symposium on Myelodysplastic Syndromes , pp.5123, 2015
SEVİNDİK, Ö. G. Et Al. (2015) . "Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities." 13 th International Symposium on Myelodysplastic Syndromes , p.5123.
@conferencepaper{conferencepaper, author={Ömür Gökmen SEVİNDİK Et Al. }, title={Hypoalbuminemia is a surrogate biomarker of poor prognosis in mylodysplastic syndrome even when adjusted with comorbities}, congress name={13 th International Symposium on Myelodysplastic Syndromes}, city={}, country={}, year={2015}, pages={5123} }